Jinsook Son

Publication Activity (10 Years)

Years Active: 2023-2024
Publications (10 Years): 11

Top Topics

Glycemic Control

Cardiovascular Disease

Skeletal Muscle

Top Venues

Nature communications

Science translational medicine

Experimental & molecular medicine

The Journal of clinical endocrinology and metabolism

This page only lists publications with an associated author ORCID identifier.

Publications

Jinsook Son, Domenico Accili
Dedifferentiation as a stealthy disruptor of β-cell function in diabetes. The Journal of clinical endocrinology and metabolism (2024)
Jinsook Son, Wen Du, Mark Esposito, Kaavian Shariati, Hongxu Ding, Yibin Kang, Domenico Accili
Genetic and pharmacologic inhibition of ALDH1A3 as a treatment of β-cell failure. Nature communications 14 (1) (2023)
Hitoshi Watanabe, Wen Du, Jinsook Son, Lina Sui, Shun-Ichiro Asahara, Irwin J Kurland, Taiyi Kuo, Takumi Kitamoto, Yasutaka Miyachi, Rafael de Cabo, Domenico Accili
Cyb5r3-based mechanism and reversal of secondary failure to sulfonylurea in diabetes. Science translational medicine 15 (681) (2023)
Jinsook Son, Wen Du, Mark Esposito, Kaavian Shariati, Hongxu Ding, Yibin Kang, Domenico Accili
Genetic and pharmacologic inhibition of ALDH1A3 as a treatment of β-cell failure. Nature communications 14 (1) (2023)
Jinsook Son, Wen Du, Mark Esposito, Kaavian Shariati, Hongxu Ding, Yibin Kang, Domenico Accili
Genetic and pharmacologic inhibition of ALDH1A3 as a treatment of β-cell failure. Nature communications 14 (1) (2023)
Jinsook Son, Wen Du, Mark Esposito, Kaavian Shariati, Hongxu Ding, Yibin Kang, Domenico Accili
Genetic and pharmacologic inhibition of ALDH1A3 as a treatment of β-cell failure. Nature communications 14 (1) (2023)
Jinsook Son, Domenico Accili
Reversing pancreatic β-cell dedifferentiation in the treatment of type 2 diabetes. Experimental & molecular medicine (2023)
Jinsook Son, Wen Du, Mark Esposito, Kaavian Shariati, Hongxu Ding, Yibin Kang, Domenico Accili
Genetic and pharmacologic inhibition of ALDH1A3 as a treatment of β-cell failure. Nature communications 14 (1) (2023)
Hitoshi Watanabe, Wen Du, Jinsook Son, Lina Sui, Shun-Ichiro Asahara, Irwin J Kurland, Taiyi Kuo, Takumi Kitamoto, Yasutaka Miyachi, Rafael de Cabo, Domenico Accili
Cyb5r3-based mechanism and reversal of secondary failure to sulfonylurea in diabetes. Science translational medicine 15 (681) (2023)
Jinsook Son, Wen Du, Mark Esposito, Kaavian Shariati, Hongxu Ding, Yibin Kang, Domenico Accili
Genetic and pharmacologic inhibition of ALDH1A3 as a treatment of β-cell failure. Nature communications 14 (1) (2023)
Hitoshi Watanabe, Wen Du, Jinsook Son, Lina Sui, Shun-Ichiro Asahara, Irwin J Kurland, Taiyi Kuo, Takumi Kitamoto, Yasutaka Miyachi, Rafael de Cabo, Domenico Accili
Cyb5r3-based mechanism and reversal of secondary failure to sulfonylurea in diabetes. Science translational medicine 15 (681) (2023)